- Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q, Masuda T, Kuramitsu S, Tobo T, Sato K, Kidogami S, Nambara S, Ueda M, Tsuruda Y, Kuroda Y, Ito S, Oki E, Mori M, Mimori K.
PLoS One. 2020 Oct 23;15(10):e0241140. doi: 10.1371/journal.pone.0241140. eCollection 2020.
PMID: 33095806
- A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer.
Masuda T, Nonami A, Tanaka F, Ando Y, Eto M, Mimori K.
Breast J. 2020 Dec;26(12):2420-2423. doi: 10.1111/tbj.14108. Epub 2020 Dec 5.
PMID: 33277749
- Genetic landscape of external auditory canal squamous cell carcinoma.
Sato K, Komune N, Hongo T, Koike K, Niida A, Uchi R, Noda T, Kogo R, Matsumoto N, Yamamoto H, Masuda M, Oda Y, Mimori K, Nakagawa T.
Cancer Sci. 2020 Aug;111(8):3010-3019. doi: 10.1111/cas.14515. Epub 2020 Jul 11.
PMID: 32500594
- The Expression Level of PD-L1 ( CD274) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer
Masuda T, Noda M, Kitagawa A, Hu Q, Fujii A, Ito S, Kosai K, Ando Y, Matsumoto Y, Ohtsu H, Uchida H, Ohno S, Mimori K.
Anticancer Res. 2020 Jul;40(7):3733-3742. doi: 10.21873/anticanres.14362.
PMID: 32620612
- Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer
Ito S, Masuda T, Noda M, Hu Q, Shimizu D, Kuroda Y, Eguchi H, Tobo T, Utsunomiya T, Mimori K.
Oncology. 2020;98(7):501-511. doi: 10.1159/000506075.
PMID: 32380498
- SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma
Kidogami S, Iguchi T, Sato K, Yoshikawa Y, Hu Q, Nambara S, Komatsu H, Ueda M, Kuroda Y, Masuda T, Mori M, Doki Y, Mimori K.
Anticancer Res. 2020 May;40(5):2941-2946. doi: 10.21873/anticanres.14272.
PMID:32366446
- Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients.
Noda M, Masuda T, Ito S, Tobo T, Kitagawa A, Hu Q, Shimizu D, Eguchi H, Etoh T, Ohno S, Inomata M, Mimori K.
Ann Surg Oncol. 2020 Mar 21. doi: 10.1245/s10434-020-08375-z. Online ahead of print.
PMID:32206951
- KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma.
Kitagawa A, Masuda T, Takahashi J, Tobo T, Noda M, Kuroda Y, Hu Q, Kouyama Y, Kobayashi Y, Kuramitsu S, Sato K, Fujii A, Yoshikawa Y, Wakiyama H, Shimizu D, Tsuruda Y, Eguchi H, Doki Y, Mori M, Mimori K.
Cancer Genomics Proteomics. 2020 Mar-Apr;17(2):141-149. doi: 10.21873/cgp.20174.
PMID:32108036
- Drug repositioning in cancer: The current situation in Japan.
Masuda T, Tsuruda Y, Matsumoto Y, Uchida H, Nakayama KI, Mimori K.
Cancer Sci. 2020 Jan 19. doi: 10.1111/cas.14318. [Epub ahead of print] Review.
PMID: 31957175
- N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study.
Masuda T, Ueo H, Kai Y, Noda M, Hu Q, Sato K, Fujii A, Hayashi N, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Ohno S, Mimori K, Ueo H.
Int J Mol Sci. 2020 Jan 14;21(2). pii: E511. doi: 10.3390/ijms21020511.
PMID: 31947504
- Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer.
Masuda T, Noda M, Kogawa T, Kitagawa D, Hayashi N, Jomori T, Nakanishi Y, Nakayama KI, Ohno S, Mimori K.
Cancer Sci. 2020 Mar;111(3):924-931. doi: 10.1111/cas.14306. Epub 2020 Feb 11.
PMID: 31943636
- GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
Nambara S, Masuda T, Kobayashi Y, Sato K, Tobo T, Koike K, Noda M, Ogawa Y, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Mimori K.
Cancer Sci. 2020 Feb;111(2):343-355. doi: 10.1111/cas.14248. Epub 2019 Dec 27.
PMID: 31758608